Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker class drugs

4 results
Alembic Pharmaceuticals Inc.
Usage: Ivabradine is indicated for adult patients with stable, symptomatic chronic heart failure and a left ventricular ejection fraction ≤ 35%. It helps reduce hospitalization risk for worsening heart failure in those with a resting heart rate ≥ 70 bpm, who are on maximum beta-blocker doses or cannot use beta-blockers.
Alembic Pharmaceuticals Limited
Usage: Ivabradine is indicated for reducing hospitalization risk due to worsening heart failure in adult patients with stable, symptomatic chronic heart failure (left ventricular ejection fraction ≤ 35%) who are in sinus rhythm, have a resting heart rate ≥ 70 bpm, and are on maximally tolerated beta-blocker doses or cannot use them.
Ingenus Pharmaceuticals, LLC
Usage: Ivabradine tablets are indicated for adult patients with stable, symptomatic chronic heart failure (left ventricular ejection fraction ≤ 35%) to reduce hospitalization risk. Eligible patients are in sinus rhythm with a resting heart rate ≥ 70 bpm and either on maximum beta-blocker doses or unable to use beta-blockers.
Zydus Lifesciences Limited